Firefly neuroscience closes on financing of up to $12.4 million

Toronto, dec. 31, 2024 (globe newswire) -- firefly neuroscience, inc. (“firefly,” “we,” or the “company”) (nasdaq: aiff), an artificial intelligence (“ai”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the closing of up to $12.4 million consisting of $2.4 million up front in the form of senior secured convertible notes at $3.00 per share, subject to adjustment, and an equity line of credit (the “eloc”) for up to $10 million. the proceeds from these financings will be used for growth, commercialization of its fda-510(k) cleared brain network analytics (bna™) technology, and general working capital purposes.
AIFF Ratings Summary
AIFF Quant Ranking